Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium and Salmeterol Combination in COPD
NCT02242253Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2003
- Primary completion
- Jul 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tiotropium, salmeterol in chronic obstructive pulmonary disease (COPD), sponsored by Boehringer Ingelheim. Started Sep 2003; status: completed.
02
Drugs
tiotropiumsalmeterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02242253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02242253.